BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1969869)

  • 1. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
    Tinkelman DG; DeJong R; Lutz C; Spangler DL
    J Allergy Clin Immunol; 1990 Apr; 85(4):719-28. PubMed ID: 1969869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
    Boner AL; Zanotto CE; Piacentini G; Miglioranzi P; Richelli C; Sette L
    J Asthma; 1990; 27(1):21-30. PubMed ID: 2137815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
    Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
    J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
    Dahl R; Harving H; Henriksen J; Rønne K; Schøler P
    Allergy; 1985 Oct; 40(7):501-5. PubMed ID: 2933998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
    Mazza JA; Tashkin DP; Reed CE
    Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procaterol metered-dose inhaler: a multiclinic study evaluating the efficacy and safety in patients with asthma.
    Storms WW; Chervinsky P; Bell T; Kemp JP; Brandon ML; Reed CE; Siegel SC; Repsher L
    Ann Allergy; 1989 Nov; 63(5):444-8. PubMed ID: 2573298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
    Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
    Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.
    Kemp JP; Welch MJ; Meltzer EO; Orgel HA
    Ann Allergy; 1985 Oct; 55(4):588-92. PubMed ID: 2864890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
    Tukiainen H; Jaakkola J; Torkko M; Terho EO
    Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of oral procaterol and albuterol in reversible airflow obstruction.
    Petty TL; Brandon ML; Busse WW; Chervinsky P; Schoenweter W; Beaupre A; Boulet LP; Mazza J
    Am Rev Respir Dis; 1988 Dec; 138(6):1504-9. PubMed ID: 2974263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procaterol metered-dose inhaler in adults with asthma.
    Storms WW; Bodman SF; Nathan RA; Wilson JM
    Ann Allergy; 1985 Sep; 55(3):476-8. PubMed ID: 2931040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of procaterol on arterial blood gas in asthmatic children.
    Obata T; Masaki T; Ilkura Y
    Ann Allergy; 1990 Nov; 65(5):389-92. PubMed ID: 1978769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma.
    Newnham DM; McDevitt DG; Lipworth BJ
    Am J Med; 1994 Jul; 97(1):29-37. PubMed ID: 7913292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
    Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
    Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma.
    Crowe MJ; Counihan HE; O'Malley K
    Br J Clin Pharmacol; 1985 Jun; 19(6):787-91. PubMed ID: 2862893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of solution and suspension type aerosol of formoterol on tremor response and airways in patients with asthma.
    Bauer K; Sertl K; Kaik B; Kaik G
    J Allergy Clin Immunol; 1995 Oct; 96(4):495-501. PubMed ID: 7560661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
    Tinkelman DG; Lutz C
    Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.